High-Dose-Rate Brachytherapy Schedules in Locally Advanced Cervical Cancer : A Systematic Review

Authors

  • Pongnikorn D, Asakit T, Chueasamran S, Rueansri J, Wiangnin J, Pakkajeerasakul P

Keywords:

High dose rate brachytherapy, Cervical cancer

Downloads

Download data is not yet available.

References

Thiravud Khuhaprema, Pattarawin Attasara, Hutcha Sriplung, Suraporn Wiangnon, Yupa Sumitsawan, Suleeporn Sangrajrang, et al. Cancer in Thailand (204-2006). [Internet].2554. [cited 2016 Jun 14]. Available from: http://www. nci.go.th/en/File_download/ Nci%20Cancer%20 Registry/Cancer%20in%20thailand.pdf.

งานทะเบียนมะเร็ง โรงพยาบาลมะเร็งลำปาง. สถิติโรคมะเร็ง โรงพยาบาลมะเร็งลำปาง ปี พ.ศ. 2554. ลำปาง: ธนกิจการพิมพ์; 2554.

ปิยวัฒน์ เลาวหุตานนท์, อาคม ชัยวีระวัฒน์, เสาวคนธ์ ศุกรโยธิน, วีรวุฒิ อิ่มสาราญ, ธีรวุฒิ คูหะเปรมะ.แนวทางการตรวจคัดกรองวินิจฉัยและรักษาโรคมะเร็งปากมดลูก. กรงุเทพมหานคร: โฆสิตการพิมพ;์ 2556.

DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins; 2008. 17-48.

Treatment options for cervical cancer, by stage [Internet]. 2558. [cited 2016 Jun 14]. Available from: http://www.cancer.org/cancer/ cervicalcancer/detailedguide/cervical-cancertreating-by-stage

Perez CA, Breaux S, Bedwinek JM, Madoc-Jones H, Camel HM, Purdy JA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984; 54:235–46.

International Commission on Radiation Units & Measurements. Dose and Volume Specification for Reporting Intracavity Therapy in Gynecology [Internet]. 2016. [cited 2016 July 25]. Available from: https://www.scribd.com/doc/72099642/ icru-38.

Viani GA, Manta GB, Stefano EJ, de Fendi LI. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials. J Exp Clin Cancer Res 2009; 28:47.

Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 2012; 11:47–52.

Tigeneh W, Kotzen J, Donde B. Prospective randomised study comparing three-fraction regimens of High Dose Rate Brachytherapy for cancer of the cervix stage IIB and IIIB. Afr J Haematol Oncol [Internet]. 2011 [cited 2016 Jul 4]. Available from: http://www.afjho.com/index. php/AJOHAO/article/view/27.

Forrest JL, Ackerman I, Barbera L, Barnes EA, Davidson M, Kiss A, et al. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix. Int J Gynecol Cancer 2010; 20:1074–8.

Tharavichitkul E, Klunkin P, Lorvidhaya V, Sukthomya V, Chakrabhandu S, Pukanhaphan N, et al. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand. J Radiat Res 2012; 53:281–7.

Julian PT, Douglas G, Jonathan AC, editors. 8 Assessing risk of bias in included studies [Internet]. 2011 [cited 2016 July 25]. Available from: http://handbook.cochrane.org/index. htm#chapter_8

Nam TK, Ahn SJ. A prospective randomized study on two dose fractionation regimens of high-dose-rate brachytherapy for carcinoma of the uterine cervix: comparison of efficacies and toxicities between two regimens. J Korean Med Sci 2004; 19:87–94.

Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. Highdose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001; 50:1123–35.

Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999; 43:359–66.

Orton CG. HDR: forget not “time” and “distance”. Int J Radiat Oncol Biol Phys 1991; 20:1131–2.

Toita T. Current status and perspectives of brachytherapy for cervical cancer. Int J Clin Oncol 2009; 14:25–30.

Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 2003; 55:1013–8.

Published

01-10-2017

How to Cite

1.
ดลสุข พงษ์นิกร พ.บ., ทัศน์วรรณ อาษากิจ พ.บ., ศิริรัตน์ เชื้อสำราญ พ.บ., จำเนียรพันธ เรือนศรี วท.ม., เจนวิทย์ เวียงนิล ส.ม., พัชยา ภัคจีรสกุล วท.บ. High-Dose-Rate Brachytherapy Schedules in Locally Advanced Cervical Cancer : A Systematic Review. j dept med ser [Internet]. 2017 Oct. 1 [cited 2022 Aug. 15];42(5):78-84. Available from: https://he02.tci-thaijo.org/index.php/JDMS/article/view/248815

Issue

Section

Original Article